Data from University of Auckland Advance Knowledge in Vaccines

2011 JUN 29 -- "Due to a dramatic increase in reported febrile convulsions in Western Australia following a routine pediatric influenza vaccination programme we evaluated parental recall of fever in their child following 2010 trivalent influenza vaccine manufactured by either Sanofi Pasteur (Vaxigrip ®) or CSL Biotherapies (Fluvax ®) to determine if the rates of febrile events in infants and children 5 years and under following administration of either Vaxigrip ® or Fluvax ® were significantly different. A convenience sample of New Zealand General practices who had received stocks of the vaccines of interest consecutively contacted parents of infants and...

Want to see the full article?

• Purchase this article for only $3.00